NCT01854229 2023-10-18
Prometra Post-Approval Study
Flowonix Medical
Phase NA Completed
Clinical Trials
11 trialsNCT02367820 2021-06-22
SUMMIT-LTS
Nektar Therapeutics
Phase 3 Completed
NCT00696137 2019-09-24
Long-term Extension Study of BEMAâ„¢ Fentanyl
BioDelivery Sciences International
Phase 3 Completed
NCT02603705 2018-03-05
Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
Egalet Ltd
Phase 3 Completed
NCT01185470 2017-04-24
The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain
Medallion Therapeutics, Inc.
Phase 2/3 Completed
NCT03105765 2017-04-10
Acute and Chronic Pain, Especially Neuropathic Pain, After Thoracotomy and Continuous Application of Ketamine.
Dr. Horst Schmidt Klinik GmbH
Phase NA Completed
NCT01902524 2014-08-28
Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain
Janssen Korea, Ltd., Korea
Phase 4 Completed
NCT00984334 2013-12-27
Naloxone SR Capsules in Patients With Opioid Induced Constipation
S.L.A. Pharma AG
Phase 2 Completed
NCT01688583 2013-11-21
The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement
Janssen Korea, Ltd., Korea
Completed
NCT00410748 2010-04-27
Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)
Alza Corporation, DE, USA
Phase 3 Completed
NCT00911261 2010-02-15
Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
Endo Pharmaceuticals
Phase 3 Completed